In In re MetLife Inc. Derivative Litig., 2020 WL 4746635 (Del. Ch. Aug. 17, 2020), the Delaware Chancery Court dismissed Caremark claims against MetLife for compliance issues within its pension risk transfer business. While the plaintiffs alleged the board became aware of compliance weaknesses in that business segment before regulators initiated enforcement actions, the court held that in context, the board's failure to take immediate corrective action did not support an inference of bad faith. While plaintiffs continued to struggle to gain traction with Caremark claims in Delaware courts, there were two cases of note where the Delaware Chancery Court permitted Caremark claims to proceed beyond the pleadings stage. Both relied heavily on Marchand. In Teamsters Local 443 Health Services & Ins. Plan v.